Our system is currently under heavy load due to increased usage. We're actively working on upgrades to improve performance. Thank you for your patience.
2024
DOI: 10.1016/j.ymthe.2024.02.033
|View full text |Cite
|
Sign up to set email alerts
|

ASOs are an effective treatment for disease-associated oligodendrocyte signatures in premanifest and symptomatic SCA3 mice

Kristen H. Schuster,
Annie J. Zalon,
Danielle M. DiFranco
et al.
Help me understand this report
View preprint versions

Search citation statements

Order By: Relevance

Paper Sections

Select...

Citation Types

0
0
0

Year Published

2024
2024
2024
2024

Publication Types

Select...
2

Relationship

0
2

Authors

Journals

citations
Cited by 2 publications
references
References 53 publications
0
0
0
Order By: Relevance